Company news
Henan Lingrui Pharmaceutial Co., Ltd. Class A (SSE:600285) news
Henan Lingrui Pharmaceutial Co., Ltd. Class A news releases on 6ix. Latest, Sep 30, 2026: (600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement…
Press releases & updates
(600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge and Re-pledge of Certain Shares Held by Major Shareholder
September 29, 2026
"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Pledge of Certain Shares Held by Major Shareholder
August 21, 2026
"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Semi-annual Report for 2026
August 11, 2026
"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge and Re-pledge of Certain Shares Held by Major Shareholder
August 4, 2026
"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Inclusion of Products of the Company and Its Subsidiaries in the "National Essential Medicines List (2026 Edition)"
July 10, 2026
Announcement on Obtaining Notice of Approval for Drug Supplementary Application
June 23, 2026
Announcement on Resolutions of the 2nd Meeting of the 10th Board of Directors
June 11, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 4, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 21, 2026
Announcement on Election of Employee Representative Directors for the 10th Board of Directors
May 20, 2026
Announcement on the Release of Pledge of Partial Shares by Major Shareholders
April 29, 2026
Announcement on Obtaining Drug Registration Certificate
April 28, 2026
Announcement on Renewing Engagement of Accounting Firm
April 27, 2026
Announcement on the Pledge of Partial Shares by the Majority Shareholders
March 24, 2026
Announcement on Results of Shareholding Reduction by Director
January 14, 2026
Announcement on "Corporate Value and Return Enhancement" Action Plan
December 31, 2025
Announcement on Resignation of Senior Management Member
December 30, 2025
羚锐制药关于选举第九届董事会职工代表董事的公告
November 18, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 10, 2025
Announcement on Canceling the Board of Supervisors and Amending the Articles of Association and Some Corporate Governance Systems
October 29, 2025
Announcement on Shareholding Reduction Plan for Directors
September 15, 2025
2025 Semi-annual Report
August 19, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
August 15, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 12, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 20, 2025
Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Henan Jurisdiction
May 16, 2025
Announcement on Additional Subscription of Private Fund Shares
April 25, 2025
Announcement on the Release of Pledge of Some Shares of Major Shareholders
March 20, 2025
Announcement on Release of Pledge and Re-pledge of Some Shares of Major Shareholders
March 6, 2025
Announcement on the Progress of Acquisition of 90% Equity of Yingu Pharmaceutical Co., Ltd.
March 4, 2025
Announcement on Pledge of Partial Shares of Major Shareholders
February 26, 2025
Announcement on Acquisition of 90% Equity of Yingu Pharmaceutical Co., Ltd.
January 27, 2025
Announcement on Completion and Termination of Stock Sales under Employee Stock Ownership Plan 2021
January 22, 2025
Announcement on Resolutions of the 1st Holders' Meeting for 2024 Employee Stock Ownership Plan
January 10, 2025
Announcement on Completion of Non-trading Transfer under the 2024 Employee Stock Ownership Plan
January 8, 2025
Announcement on Progress in Changing Nature of Shares and Granting Equities under 2024 Restricted Stock Incentive Plan
January 7, 2025
Announcement on Company Products' Expected Winning of the Bid for National TCM Preparations Joint Procurement Alliance's Centralized Volume-based Procurement Agreement
January 2, 2025
Announcement on Granting Equity under 2024 Restricted Stock Incentive Plan
December 19, 2024
Announcement on Resolution of the 1st Extraordinary General Meeting in 2024
December 18, 2024
Announcement on Board of Supervisors' Remarks on Publicity of and Verification Opinions on List of Incentive Objects under 2024 Restricted Stock Incentive Plan
December 10, 2024
Announcement on Signing Intention Agreement for Equity Acquisition
December 4, 2024
Announcement on Changing Registered Capital and Business Scope and Amending the Articles of Association
November 29, 2024
Announcement on Convening the Q3 2024 Performance Briefing
November 6, 2024
Report for Q3 2024
October 29, 2024
Announcement on Implementing Repurchase and Cancellation of Restricted Stocks in Equity Incentive
August 20, 2024
Announcement on Convening Semi-annual Performance Briefing 2024
August 12, 2024
Announcement on Unlocking and Listing of the 3rd Phase of Restricted Stock for 2021
July 22, 2024
Announcement on Proposed Repurchasing and Canceling of Some Restricted Shares and Adjustment of Repurchase Price
June 26, 2024